PUBLISHER: The Business Research Company | PRODUCT CODE: 1946935
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946935
Pediatric interventional cardiology involves utilizing cardiac catheterization in children to both diagnose and treat congenital heart defects through minimally invasive procedures. These procedures aim to address various heart conditions while minimizing surgical invasiveness.
Key devices within pediatric interventional cardiology encompass closure devices, trans catheter heart valves, atherectomy devices, catheters, balloons, stents, among others. Closure devices encompass a range of fittings that, when securely fastened in a closed position, mitigate or prevent air emissions by sealing openings in containers or their exteriors. The primary procedures in pediatric interventional cardiology involve catheter-based valve implantation, correction of congenital heart defects, angioplasty, coronary thrombectomy, and other methodologies. These procedures find application in clinical testing labs, hospitals, cardiac centers, pediatric clinics, and research institutions, contributing significantly to diagnosing and managing cardiac conditions in children.
Tariffs are influencing the pediatric interventional cardiology market by increasing costs of imported catheters, stents, valves, imaging components, and precision-manufactured cardiac devices. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on imported specialized devices, while Asia-Pacific faces higher manufacturing and export costs. These tariffs are increasing procedural costs and impacting device procurement. However, they are also encouraging regional device manufacturing, local supplier development, and innovation in cost-optimized pediatric cardiac solutions.
The pediatric interventional cardiology market research report is one of a series of new reports from The Business Research Company that provides pediatric interventional cardiology market statistics, including pediatric interventional cardiology industry global market size, regional shares, competitors with a pediatric interventional cardiology market share, detailed pediatric interventional cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric interventional cardiology industry. This pediatric interventional cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric interventional cardiology market size has grown strongly in recent years. It will grow from $2.6 billion in 2025 to $2.81 billion in 2026 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to improvements in catheter-based intervention techniques, rising diagnosis of congenital heart defects, expansion of pediatric cardiac care centers, advancements in interventional imaging, increased surgeon expertise in minimally invasive procedures.
The pediatric interventional cardiology market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to expansion of next-generation pediatric cardiac devices, rising demand for less invasive treatment options, growing investments in pediatric cardiac infrastructure, integration of advanced imaging and navigation systems, increasing procedural success rates. Major trends in the forecast period include increasing adoption of minimally invasive cardiac procedures, rising use of transcatheter heart valves, growing demand for pediatric-specific cardiac devices, expansion of image-guided catheterization techniques, enhanced focus on early congenital defect intervention.
The increasing prevalence of congenital heart disease is expected to drive the growth of the pediatric interventional cardiology market. Congenital heart disease refers to structural or functional abnormalities of the heart present at birth. Pediatric interventional cardiology procedures, such as catheter-based interventions, offer advantages over traditional open-heart surgery, including shorter recovery times, reduced risk of infection, and minimal scarring. For instance, in October 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, heart defects are the most common birth defects in the United States, affecting approximately 1% of all births-around 40,000 infants annually. This rising prevalence underscores the growing need for minimally invasive cardiac procedures in pediatric populations, thereby propelling market growth.
Pedistric population drives the pediatric interventional cardiology market going forward. This demographic refers to individuals within specific age brackets typically associated with childhood and adolescence. According to the Federal Interagency Forum on Child and Family Statistics, the U.S. had around 72.5 million children in 2022, projected to reach 78.2 million by 2050. The rise in this population, spanning different age groups, is expected to fuel the demand for pediatric interventional cardiology procedures.
Major companies in the pediatric interventional cardiology market are prioritizing the development of technological innovations, such as three-dimensional transesophageal echocardiography (3D TEE), to secure a competitive advantage. In pediatric interventional cardiology, real-time 3D TEE provides intricate images of congenital heart defects, including atrial and ventricular septal defects, which are vital for planning and guiding minimally invasive procedures. For example, in January 2024, Philips, a healthcare technology company based in the Netherlands, launched the X11-4T Mini 3D TEE transducer. This state-of-the-art transducer enhances three-dimensional transesophageal echocardiography (TEE) by delivering detailed imaging essential for diagnosing congenital heart defects in children. Notable features include its compact design, which improves maneuverability in pediatric patients, high-resolution imaging capabilities that boost diagnostic accuracy, and compatibility with existing echocardiography systems for a seamless workflow. These advancements substantially enhance procedural outcomes and patient care within pediatric cardiology.
Major companies operating in the pediatric interventional cardiology market are Medtronic plc, Abbott Laboratories, Terumo Corporation, W. L. Gore & Associates Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Numed Inc., St. Jude Medical Inc., Cordis Corporation, Koninklijke Philips N.V., Biotronik, B. Braun Melsungen AG, Johnson and Johnson, Cook Group LLC, Teleflex Incorporated, Merit Medical Systems Inc., MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Biosensors International Group Ltd., Asahi Intecc Co Ltd, Medinol Ltd., Jotec GmbH, Hexacath Ltd., Translumina GmbH
North America was the largest region in the pediatric interventional cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pediatric interventional cardiology market during the forecast period. The regions covered in the pediatric interventional cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric interventional cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pediatric interventional cardiology market includes revenues earned by entities by percutaneous coronary intervention services, atrial septal defect services, cardiac catheterization services, and trans catheter aortic valve replacement services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The pediatric interventional cardiology market also consists of sales of plaque modification devices, guide wire, vascular closure devices, and atherectomy device. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric Interventional Cardiology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pediatric interventional cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric interventional cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric interventional cardiology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.